MedTrace Logo

Toronto Thromboprophylaxis Patient Safety Initiative

NCT01869075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1895

Last updated 2014-09-23

Study results available
· View outcomes & findings →

Summary

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE, is one of the common and preventable complications of hospital stay. VTE prophylaxis through the use of evidence-based anticoagulant medication options or mechanical prophylaxis have been shown to reduce this risk and improve patient safety. Despite an abundance of evidence, use of VTE prophylaxis remains low.

This study assesses the effectiveness of quality improvement strategies (use of pre-printed orders, audit and feedback, involvement of the pharmacist as project need and as a reminder to the physician, and education of staff) on use of appropriate VTE prophylaxis. The study aims to measure if the use of these strategies improves the use of VTE prophylaxis and therefore, improves patient safety and patient care by reducing the risk of developing DVT or PE.

Conditions

  • Venous Thromboembolism

Interventions

OTHER

Knowledge Translation (KT) toolkit

KT toolkit consists of: use of pre-printed orders, use of pharmacist as project lead and human reminder for prescribing, audit and feedback, education for staff

Sponsors & Collaborators

  • North York General Hospital

    collaborator OTHER

  • Michael Garron Hospital

    collaborator OTHER

  • Trillium Health Centre

    collaborator OTHER

  • Lakeridge Health Corporation

    collaborator OTHER

  • York Central Hospital, Ontario

    collaborator OTHER

  • Scarborough General Hospital

    collaborator OTHER

  • Markham Stouffville Hospital

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • William H Geerts, MD · Sunnybrook Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01869075 on ClinicalTrials.gov